Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
BRITISH JOURNAL OF HAEMATOLOGY（2022）
关键词
Idelalisib, relapsed, refractory DLBCL, transformed lymphoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要